JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren, um alle Funktionen in diesem Shop nutzen zu können.
Burkitt lymphoma
Established from the inguinal tumor of an EBV-negative 5-year-old African girl with Burkitt lymphoma at the preterminal stage.
Homo sapiens Tissue:Peripheral blood Morphology:Round to polymorphic cells Properties: Cells growing in suspension, singly and in clumps Cytogenic data:human hypodiploid karyotype; 44(40-46)< 2n> XX, -10, -21, der(6)t(6; 10)(p22; p12), der(7)t(1; 7)(p36; p22), t(11; 17)(q24; q24), der(11)t(11; 17)(q24; q24)t(11; 6)(p15; q11)t(6; 5)(q22; ?), ider(13)(q10)t(3; 13)(q26; q14), der(13)t(10; 13)(q11; p11)dup(13)(q11q32)t(13; 21)(q32; q22), der(21)t(13; 21); no IG/MYC translocation detected Patient: African female, 5 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 20% FBS Subculture:Seed cells at approximately 6 x 105 cells/ml; optimal split ratio 1:2 every 2-3 days; culture flask should be kept horizontal. Although the tumor tissue was experimentally exposed to EBV, neither EBV sequences nor EBV antigens were detectable in the established cell line. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Peripheral blood Morphology:Round to polymorphic cells Properties: Cells growing in suspension, singly and in clumps Cytogenic data:human hypodiploid karyotype; 44(40-46)< 2n> XX, -10, -21, der(6)t(6; 10)(p22; p12), der(7)t(1; 7)(p36; p22), t(11; 17)(q24; q24), der(11)t(11; 17)(q24; q24)t(11; 6)(p15; q11)t(6; 5)(q22; ?), ider(13)(q10)t(3; 13)(q26; q14), der(13)t(10; 13)(q11; p11)dup(13)(q11q32)t(13; 21)(q32; q22), der(21)t(13; 21); no IG/MYC translocation detected Patient: African female, 5 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 20% FBS Subculture:Seed cells at approximately 6 x 105 cells/ml; optimal split ratio 1:2 every 2-3 days; culture flask should be kept horizontal. Although the tumor tissue was experimentally exposed to EBV, neither EBV sequences nor EBV antigens were detectable in the established cell line. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Round to polymorphic cells Properties: Cells growing in suspension, singly and in clumps Cytogenic data:human hypodiploid karyotype; 44(40-46)< 2n> XX, -10, -21, der(6)t(6; 10)(p22; p12), der(7)t(1; 7)(p36; p22), t(11; 17)(q24; q24), der(11)t(11; 17)(q24; q24)t(11; 6)(p15; q11)t(6; 5)(q22; ?), ider(13)(q10)t(3; 13)(q26; q14), der(13)t(10; 13)(q11; p11)dup(13)(q11q32)t(13; 21)(q32; q22), der(21)t(13; 21); no IG/MYC translocation detected Patient: African female, 5 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 20% FBS Subculture:Seed cells at approximately 6 x 105 cells/ml; optimal split ratio 1:2 every 2-3 days; culture flask should be kept horizontal. Although the tumor tissue was experimentally exposed to EBV, neither EBV sequences nor EBV antigens were detectable in the established cell line. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Cells growing in suspension, singly and in clumps Cytogenic data:human hypodiploid karyotype; 44(40-46)< 2n> XX, -10, -21, der(6)t(6; 10)(p22; p12), der(7)t(1; 7)(p36; p22), t(11; 17)(q24; q24), der(11)t(11; 17)(q24; q24)t(11; 6)(p15; q11)t(6; 5)(q22; ?), ider(13)(q10)t(3; 13)(q26; q14), der(13)t(10; 13)(q11; p11)dup(13)(q11q32)t(13; 21)(q32; q22), der(21)t(13; 21); no IG/MYC translocation detected Patient: African female, 5 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 20% FBS Subculture:Seed cells at approximately 6 x 105 cells/ml; optimal split ratio 1:2 every 2-3 days; culture flask should be kept horizontal. Although the tumor tissue was experimentally exposed to EBV, neither EBV sequences nor EBV antigens were detectable in the established cell line. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
human hypodiploid karyotype; 44(40-46)< 2n> XX, -10, -21, der(6)t(6; 10)(p22; p12), der(7)t(1; 7)(p36; p22), t(11; 17)(q24; q24), der(11)t(11; 17)(q24; q24)t(11; 6)(p15; q11)t(6; 5)(q22; ?), ider(13)(q10)t(3; 13)(q26; q14), der(13)t(10; 13)(q11; p11)dup(13)(q11q32)t(13; 21)(q32; q22), der(21)t(13; 21); no IG/MYC translocation detected Patient: African female, 5 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 20% FBS Subculture:Seed cells at approximately 6 x 105 cells/ml; optimal split ratio 1:2 every 2-3 days; culture flask should be kept horizontal. Although the tumor tissue was experimentally exposed to EBV, neither EBV sequences nor EBV antigens were detectable in the established cell line. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
African female, 5 yrs of age Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 20% FBS Subculture:Seed cells at approximately 6 x 105 cells/ml; optimal split ratio 1:2 every 2-3 days; culture flask should be kept horizontal. Although the tumor tissue was experimentally exposed to EBV, neither EBV sequences nor EBV antigens were detectable in the established cell line. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
AddexBio-formulated RPMI-1640 Medium(C0004-01) + 20% FBS Subculture:Seed cells at approximately 6 x 105 cells/ml; optimal split ratio 1:2 every 2-3 days; culture flask should be kept horizontal. Although the tumor tissue was experimentally exposed to EBV, neither EBV sequences nor EBV antigens were detectable in the established cell line. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Seed cells at approximately 6 x 105 cells/ml; optimal split ratio 1:2 every 2-3 days; culture flask should be kept horizontal. Although the tumor tissue was experimentally exposed to EBV, neither EBV sequences nor EBV antigens were detectable in the established cell line. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Complete culture medium supplemented with 10% (v/v) DMSO
I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative
Hepatitis B: Negative Hepatitis C: Negative
Hepatitis C: Negative
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.
Arbeitsanleitung (Data Sheet) anfordern
Produkt-Datenblatt anfordern
Sicherheitsdatenblatt anfordern
Vergleichen
Auf den Wunschzettel
Angebot anfordern
Lieferzeit anfragen
Technische Frage stellen
Bulk-Anfrage stellen
sales@hoelzel.de
« Zurück
Pünktliche Lieferung zu Ihrem Wunschtermin und bei jeder 5. Bestellung 15% sparen.
Passwort vergessen?
Noch nicht registriert? Konto hier erstellen!